Your browser doesn't support javascript.
loading
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.
Desikan, Sai Prasad; Senapati, Jayastu; Jabbour, Elias; Abuasab, Tareq; Short, Nicholas; Tang, Guilin; Wang, Sa; Kebriaei, Partow; Kadia, Tapan; Borthakur, Gautam; Ravandi, Farhad; Roberts, Kathryn; Mullighan, Charles; Konopleva, Marina; Kantarjian, Hagop; Jain, Nitin.
Afiliação
  • Desikan SP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abuasab T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kebriaei P; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Roberts K; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mullighan C; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 98(6): E142-E144, 2023 06.
Article em En | MEDLINE | ID: mdl-36877196
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos